60
Participants
Start Date
November 7, 2023
Primary Completion Date
December 31, 2026
Study Completion Date
December 31, 2026
18F-Fluselenamyl
Participants will receive a single intravenous bolus injection of 10 mCi ± 20% of the investigational radiotracer 18F-Fluselenamyl and will undergo an 18F-Fluselenamyl PET/CT scan of the head and neck.
RECRUITING
Washington University School of Medicine, St Louis
Washington University School of Medicine
OTHER